|
Market Cap (5-Jun) $61,568,592 (1,444th) |
Close (30-Jun) $0.076 |
Volume (30-Jun) 120,981 |
Shortsold (26-May) 11,577 (0.00%) (629th) |
|
52w High $0.425 |
52w Low $0.056 |
P/E - |
EPS -0.02 |
ATX released this announcement to the ASX on 11 January 2021, 13:21. The announcement is not marked as price sensitive, and is 16 page(s) in length and 270.74kb in size.
You can view all announcements from ATX and see how they appear on a price chart on the announcements page.
At the date of this announcement, ATX was 0.024% short sold according to ASIC data. It was ranked the 485th most shorted stock on the ASX. It remains ranked 629th as of the latest reported data (26 May 2026).
| Other Recent Announcements from ATX | |
|---|---|
| AMP945 International Nonproprietary Name Narmafotinib | 21 June 2023, 8:34 |
| Amplia AGM to be held Thursday 24 August 2023 | 19 June 2023, 17:34 |
| Key to Corporate Governance Disclosures | 31 May 2023, 8:14 |
| Appendix 2A - Exercise of Options | 11 January 2021, 13:21 |
| Shareholder Update - 2020 Review | 17 December 2020, 8:21 |
| Amplia Receives $0.53m R&D Tax Incentive | 2 December 2020, 9:20 |
| Appendix 4D and Financial Report Half Year Ended 30 Sep 2020 | 27 November 2020, 16:59 |
You must be logged in to post a reply.
Amplia Therapeutics 